The effect of cortisol on plasma immunoglobulin G (IgG) levels and on jejunal transport of sodium and glucose has been investigated in neonatal pigs (0-7 days of age). Five pigs were delivered vaginally (VD) at term (114-115 days gestation) and thirty-five by caesarean section (CS) 2-4 days before term (to circumvent a neonatal cortisol surge). Postnatally, twenty-seven CS pigs were injected with adrenocorticotrophic hormone (ACTH; n = 13), metyrapone (an inhibitor of adrenal 11 beta-hydroxylase activity, n = 7) or physiological saline (n = 7). Pigs were killed at birth, at 3 days, or at 6-7 days of age. Plasma concentrations of cortisol and IgG were determined and unidirectional fluxes of sodium and glucose measured across the proximal jejunum in vitro. Newborn CS pigs had significantly lower plasma cortisol but higher net fluxes of sodium and glucose than newborn VD pigs. At 3-7 days, metyrapone-treated pigs had significantly lower concentrations of cortisol and IgG in plasma and lower net fluxes of sodium and glucose than ACTH-treated pigs. Differences in net fluxes between treatment groups resulted from changes in both electrogenic and non-electrogenic sodium transport. Furthermore, sodium-glucose co-transport accounted for a major proportion of net sodium transport. High unidirectional fluxes in newborn CS pigs may be explained by the passage of large amounts of sodium through tight junctions and paracellular pathways in the prepartum period. The results indicate that cortisol stimulates net transport of sodium, glucose and immunoglobulins in the postnatal period of caesarean-delivered pigs. However, cortisol is unlikely to play a major regulatory role in the postnatal maturation of intestinal transport in normally delivered pigs.

Download full-text PDF

Source
http://dx.doi.org/10.1113/expphysiol.1993.sp003700DOI Listing

Publication Analysis

Top Keywords

sodium glucose
24
transport sodium
12
pigs
12
fluxes sodium
12
newborn pigs
12
net fluxes
12
sodium
9
intestinal transport
8
neonatal pigs
8
days age
8

Similar Publications

Introduction Fournier's gangrene (FG) is a rapidly progressing necrotizing fasciitis. The Fournier's Gangrene Severity Index (FGSI), in conjunction with the Charlson Comorbidity Index (CCI), has been used as a mortality predictor during hospitalization. Patients with diabetes have also been shown to be at an increased risk for the development of FG.

View Article and Find Full Text PDF

The role of multimodality imaging in diabetic cardiomyopathy: a brief review.

Front Endocrinol (Lausanne)

December 2024

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.

Diabetic cardiomyopathy (DMCM), defined as left ventricular dysfunction in the setting of diabetes mellitus without hypertension, coronary artery disease or valvular heart disease, is a well-recognized entity whose prevalence is certainly predicted to increase alongside the rising incidence and prevalence of diabetes mellitus. The pathophysiology of DMCM stems from hyperglycemia and insulin resistance, resulting in oxidative stress, inflammation, cardiomyocyte death, and fibrosis. These perturbations lead to left ventricular hypertrophy with associated impaired relaxation early in the course of the disease, and eventually culminating in combined systolic and diastolic heart failure.

View Article and Find Full Text PDF

Introduction: The progression of diabetes status in post-stroke patients remains under-investigated, particularly regarding new treatments for type II diabetes mellitus (DM II), like glucagon-like peptide 1 receptor agonists (GLP-1-RA) and sodium-glucose co-transporter-2 (SGLT-2) inhibitors, which have not been studied in the post-stroke setting.

Patients And Methods: Eight hundred eighty-four consecutive ischemic stroke patients recruited to our prospective STROKE-CARD Registry were assessed concerning their glycemic status at baseline (normoglycemia, prediabetes, DM II) and change over time within 1 year follow-up. Multivariate logistic regression was performed to identify factors associated with transitioning from normoglycemia to prediabetes or DM II.

View Article and Find Full Text PDF

Machine learning derivation of two cardiac arrest subphenotypes with distinct responses to treatment.

J Transl Med

January 2025

Fourth Clinical Medical College of Zhejiang Chinese Medical University, Zhejiang, 310006, Hangzhou, China.

Introduction: Cardiac arrest (CA), characterized by its heterogeneity, poses challenges in patient management. This study aimed to identify clinical subphenotypes in CA patients to aid in patient classification, prognosis assessment, and treatment decision-making.

Methods: For this study, comprehensive data were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) 2.

View Article and Find Full Text PDF

Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 Diabetes.

Curr Diab Rep

January 2025

Facultad de Farmacia y Bioquímica, Laboratorio de Lípidos y Aterosclerosis, Universidad de Buenos Aires, Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC-UBA), Buenos Aires, Argentina.

Purpose Of Review: This article explores the cardiovascular effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus (T2DM), with a particular focus on their impact on lipid profiles. As evidence grows of the cardiovascular benefits of SGLT2i beyond glucose control, it is essential to better understand their effects on lipoproteins and their impact on cardiovascular disease.

Recent Findings: SGLT2i have shown significant cardiovascular benefits in patients with type 2 diabetes mellitus, beyond their role in lowering blood glucose.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!